Form 4: Lemaitre Vascular Exec Sells Shares After PSU Vesting

Sentiment:

Insider Transaction Report


Lemaitre Vascular's Senior VP of Operations, Trent G. Kamke, sold 1,044 shares of common stock following the vesting of performance share units and dividend equivalent rights.

Summary

  • Trent G. Kamke, Senior V.P., Operations at Lemaitre Vascular Inc. (LMAT), reported transactions in company common stock.
  • On February 26, 2026, Kamke acquired 1,051 shares upon the settlement of a Performance Share Unit (PSU) award granted on December 6, 2024. This PSU award vested 25% upon performance condition satisfaction.
  • Also on February 26, 2026, Kamke acquired 2 shares from the release of dividend equivalent rights.
  • Concurrently, 93 shares were withheld by the issuer on February 26, 2026, at a price of $113.69 per share to cover tax withholding obligations related to the PSU vesting.
  • On February 27, 2026, Kamke sold 1,044 shares of common stock at a price of $110.29 per share.
  • Following these transactions, Kamke's direct beneficial ownership decreased from 7,812 shares (after the initial PSU acquisition) to 6,677 shares.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this as a neutral event. While the vesting of PSUs is positive, indicating performance targets were met, the subsequent net sale of shares by a Senior VP could be interpreted with slight caution, though often a routine part of executive compensation.

Positives

  • Acquisition of 1,051 shares from a Performance Share Unit (PSU) award vesting suggests that performance conditions set on December 6, 2024, were met.
  • Acquisition of 2 shares from dividend equivalent rights.

Negatives

  • Trent G. Kamke sold 1,044 shares of common stock on the open market at $110.29 per share.
  • A net decrease of 1,135 shares in beneficial ownership after all reported transactions.

Future Outlook

The balance of the Performance Share Unit (PSU) award, granted on December 6, 2024, is set to vest in equal annual installments on the grant date anniversary over the next three years.

Industry Context

StockSavvy.ai notes that insider sales, even when related to compensation vesting, are often scrutinized by investors for potential signals about management's confidence in future performance. However, the initial acquisition from PSU vesting indicates performance targets were met.

Stakeholder Impact

  • Shareholders: May view the net sale by an insider as a slight negative, but the PSU vesting confirms management met performance goals.

Next Steps

  • Remaining balance of the PSU award will vest in equal annual installments on the grant date anniversary over the next three years.

Key Dates

DateDescription
12/06/2024Grant date of Performance Share Unit (PSU) award.
02/26/2026Settlement of PSU award, release of dividend equivalent rights, and shares withheld for tax obligations.
02/27/2026Sale of common stock by reporting person.
03/02/2026Signature date of the Form 4 filing.

Recommendation

hold

This Form 4 details routine insider transactions related to executive compensation, specifically the vesting of performance share units and subsequent sales for tax obligations and personal liquidity. While there is a net sale of shares, the underlying PSU vesting indicates the company met performance targets. This type of transaction typically does not signal a fundamental shift in the company's outlook and is unlikely to warrant a change in investment thesis based solely on this filing. Therefore, a 'hold' recommendation is appropriate.

Keywords

LEMAITRE VASCULAR, LMAT, Form 4, insider trading, stock sale, PSU, performance share units, executive compensation, beneficial ownership

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.